Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 68, n° 4S1
page AB20 (avril 2013)
Doi : 10.1016/j.jaad.2012.12.086
Aesthetic Dermatology

A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of repeat treatments of crow's feet lines and glabellar lines with onabotulinumtoxina

Jean Carruthers, MD, University of British Columbia, Vancouver, BC, Canada; Alexander Rivkin, MD, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; Christine Somogyi, RN, Allergan, Inc, Irvine, CA, United States; Elisabeth Lee, MPH, Allergan, Inc, Irvine, CA, United States; Frederick Beddingfield, III, MD, PhD, Allergan, Inc, Irvine, CA, United States; Lisa Donofrio, MD, Yale University School of Medicine, New Haven, CT, United States; Vince Bertucci, MD, University of Toronto, Woodbridge, ON, Canada

 100% is sponsored by Allergan, Inc

Top of the page

© 2013  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline